| Cell capture structures | Targeted cells | Carrier medium and control cells | Target cell recovery rate | Capture purity |
| An electrode affinity column with interdigitated micro-electrodes | Human leukemic cells of HL-60 | Blood cells + sucrose solution | NA | ~80% (initial mixture of 2 × 107 HL-60 and 3 × 107 blood cells) |
| A dielectric affinity column with interdigitated micro-electrodes | Human breast cancer cells of MDA-231 | Blood samples + sucrose solution | NA | ~95% (initial mixture of 1 × 107 MDA-231 and 3 × 107 blood cells) |
| A dielectric affinity column with an interdigitated micro-electrodes | Human breast cancer cells of MDA-231 | Blood samples + sucrose solution | >95% | NA |
| A dielectric affinity column with reconfigurable electrodes | Human cervical cancer cells of HeLa | Human peripheral blood cells + sucrose solution | NA | NA |
| A dielectric affinity column with a micro-electrode array | Human monocytic cells of U937, lymphoma cells of Jurkat, HTLV-1, tax-transformed human T cells of Ind-2, glioma cells of HTB, and neuroblastoma cells of SH-SY5Y | Peripheral blood mononuclear cells + sucrose solution | 47% - 79% | >95% |
| DEP field flow fraction with interdigitated electrodes | Human leukemic cells of HL-60 | WBCs from blood samples + sucrose solution | NA | NA |
| DEP field flow fraction with interdigitated electrodes | Human breast cancer cells of MDA-435 | Hematopoietic CD34+ stem cells + sucrose solution | NA | >99% (initial MDA-435: stem cells = 2:3) |
| DEP field flow fraction with interdigitated electrodes | Human breast cancer cells of MDA-435 | Blood samples + sucrose solution | NA | >98% of MDA-435 (initialMDA-435: blood cells = 2:3) |
| DEP field flow fraction with interdigitated electrodes | Human breast cancer cells of MDA-435, MDA-468 and MDA-231 | Peripheral blood mononuclear cells + sucrose solution | >90% | NA |
| Microscope slides coated with electrode arrays with changing frequencies | Human breast cancer cells of MDA-435 and leukemic cells of HL-60 | Blood samples + sucrose | NA | NA |
| Microscope slides coated with electrode arrays with changing frequencies | Cancer cells from biopsy | Biopsied cells + sucrose solution | NA | NA |
| 3D-asymmetric micro-electrodes with a continuously varied electric field | Mouse P19 embryonic carcinoma cells | Mouse RBCs + PBS | NA | 81.5% ± 7.6% of P19 EC and 94.1% ± 4.3% RBCs (initial ratio 1:1) |
| 3D-asymmetric micro-electrodes with a continuously varied electric field | Human breast cancer cells of MCF-7 and MCF-10A | PBS | 86.67% of MCF-7 and 98.73% of MCF-10A | NA |
| DC-dielectrophoresis | Fixed WBCs and human breast cancer cells of MCF-7 | Trehalose solution | NA | NA |
| Guided DEP with a pair of planar electrodes | Human leukemic cells of Jurkat and cervical cancer cells of HeLa | Sucrose solution | NA | NA |
| Planar interdigitated Microelectrodes | Clones of mouse melanoma B16F10 cells | Sucrose solution | NA | NA |
| A planar electrode pair with an angle to the flow direction | Human colorectal cancer cells of HCT116 and embryonic kidney cells of HEK 293 | PBS | NA | 95% of HCT116 |